Ironwood Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Almirall EUR 53.03M 68.53M 2024-06
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amarin USD -25168000 24.64M 2024-09
Ardelyx USD 8.12M 5.89M 2024-12
Astellas Pharma JPY 63.52B 179.71B 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Charles River Laboratories USD 74.67M 242.36M 2025-03
Exact Sciences USD -96010000 780.34M 2025-03
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Incyte USD 205.17M 96.34M 2025-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
MacroGenics USD -16587000 70.78M 2024-12
Moderna USD -1050000000 196M 2025-03
Myriad Genetics USD -29000000 10M 2025-03
Pacira USD 24.7M 164.23M 2024-12
PTC Therapeutics USD 970.22M 1.03B 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Takeda JPY 66.94B 117.3B 2024-12
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03



Ironwood Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.